Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Carvedilol improves uptake-1 in patients with systolic congestive heart failure.
Machida M, Takechi S, Fujimoto T, Kakinoki S, Nomura A.
J Cardiovasc Pharmacol. 2012 Feb;59(2):175-81.
Related citations
Attenuated ventricular β-adrenergic response and reduced repolarization reserve in a rabbit model of chronic heart failure.
Nissen JD, Thomsen MB, Bentzen BH, Diness JG, Diness TG, Jespersen T, Grunnet M.
J Cardiovasc Pharmacol. 2012 Feb;59(2):142-50.
Brain AT1 receptor activates the sympathetic nervous system through toll-like receptor 4 in mice with heart failure.
Ogawa K, Hirooka Y, Kishi T, Sunagawa K.
J Cardiovasc Pharmacol. 2011 Nov;58(5):543-9. Erratum in: J Cardiovasc Pharmacol. 2012 Feb;59(2):206.
Adenosine receptor mRNA expression in normal and failing minipig hearts.
Del Ry S, Cabiati M, Martino A, Simioniuc A, Morales MA, Picano E.
J Cardiovasc Pharmacol. 2011 Aug;58(2):149-56.
Chronic β-adrenoceptor antagonist treatment controls cardiovascular remodeling in heart failure in the aging spontaneously hypertensive rat.
Chan V, Fenning A, Hoey A, Brown L.
J Cardiovasc Pharmacol. 2011 Oct;58(4):424-31.
Regulation of kinase cascade activation and heat shock protein expression by poly(ADP-ribose) polymerase inhibition in doxorubicin-induced heart failure.
Bartha E, Solti I, Szabo A, Olah G, Magyar K, Szabados E, Kalai T, Hideg K, Toth K, Gero D, Szabo C, Sumegi B, Halmosi R.
J Cardiovasc Pharmacol. 2011 Oct;58(4):380-91.
Cost-effectiveness of levosimendan in patients with acute heart failure.
Fedele F, D'Ambrosi A, Bruno N, Caira C, Brasolin B, Mancone M.
J Cardiovasc Pharmacol. 2011 Oct;58(4):363-6.
Management of acute cardiac failure by intracoronary administration of levosimendan.
Caimmi PP, Kapetanakis EI, Beggino C, Molinari C, Giustini G, Crosio E, Reposo G, Micalizzi E, Vacca G, Grossini E.
J Cardiovasc Pharmacol. 2011 Sep;58(3):246-53.
Newer inotropes in pediatric heart failure.
Hoffman TM.
J Cardiovasc Pharmacol. 2011 Aug;58(2):121-5. Review.
Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats.
Chan V, Fenning A, Levick SP, Loch D, Chunduri P, Iyer A, Teo YL, Hoey A, Wilson K, Burstow D, Brown L.
J Cardiovasc Pharmacol. 2011 Apr;57(4):469-78.
The role of microRNA in cardiac excitability.
Wang Z.
J Cardiovasc Pharmacol. 2010 Nov;56(5):460-70. Review.
Activation of SUR2B/Kir6.1 subtype of adenosine triphosphate-sensitive potassium channel improves pressure overload-induced cardiac remodeling via protecting endothelial function.
Tang Y, Long CL, Wang RH, Cui W, Wang H.
J Cardiovasc Pharmacol. 2010 Oct;56(4):345-53.
Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failure.
Xu K, George I, Klotz S, Hay I, Xydas S, Zhang G, Cerami A, Wang J.
J Cardiovasc Pharmacol. 2010 Nov;56(5):506-12.
Role of microRNAs in cardiovascular disease: therapeutic challenges and potentials.
Port JD, Sucharov C.
J Cardiovasc Pharmacol. 2010 Nov;56(5):444-53. Review.
Congestive heart failure: where homeostasis begets dyshomeostasis.
Kamalov G, Bhattacharya SK, Weber KT.
J Cardiovasc Pharmacol. 2010 Sep;56(3):320-8.
Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.
Mishra S, Ling H, Grimm M, Zhang T, Bers DM, Brown JH.
J Cardiovasc Pharmacol. 2010 Dec;56(6):598-603. Review.
T-wave alternans as a therapeutic marker for antiarrhythmic agents.
Verrier RL, Nieminen T.
J Cardiovasc Pharmacol. 2010 Jun;55(6):544-54. Review.
Heart rate turbulence to guide treatment for prevention of sudden death.
Bauer A, Zürn CS, Schmidt G.
J Cardiovasc Pharmacol. 2010 Jun;55(6):531-8. Review.
Lack of beta3 integrin signaling contributes to calpain-mediated myocardial cell loss in pressure-overloaded myocardium.
Suryakumar G, Kasiganesan H, Balasubramanian S, Kuppuswamy D.
J Cardiovasc Pharmacol. 2010 Jun;55(6):567-73.
Amino-terminal fragment of C-type natriuretic peptide precursor and C-type natriuretic peptide do not correlate in patients with Chagas disease: role for neutral endopeptidase.
Wang Y, Moreira Mda C, Heringer-Walther S, Schultheiss HP, Siems WE, Wessel N, Walther T.
J Cardiovasc Pharmacol. 2010 Jan;55(1):62-6.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on